Keywords: cv, fourth-quarter, loss, deepens, therapeutics, drugmaker, focused

CV's fourth-quarter 2005 loss deepens 38%

Article | 13 March 2006

Print This

CV Therapeutics, a US drugmaker focused on cardiovascular disease, says that, for the three months ended December 31, 2005, it saw a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in